MedTrace Logo

Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias

NCT02759822 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2016-05-03

No results posted yet for this study

Summary

This is a prospective observational cohort study of haploidentical transplantation with post-transplant cyclophosphamide for acute leukemias using reduced intensity conditioning for acute myeloid leukemia (AML) and myeloablative conditioning for acute lymphoblastic leukemia (ALL).

Conditions

  • Leukemia, Myeloid, Acute
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions

PROCEDURE

Haploidentical Stem Cell Transplantation

Haploidentical Stem Cell Transplantation from a related donor (partially matched sibling, father, mother, son or daughter).

Sponsors & Collaborators

  • Leonardo Javier Arcuri

    lead OTHER_GOV

Principal Investigators

  • Leonardo J Arcuri, MD · Instituto Nacional de Cancer

Eligibility

Min Age
1 Year
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2021-04-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02759822 on ClinicalTrials.gov